|
微量白蛋白尿与心血管疾病 |
|
rnlov,Evans JC,Meigs JB,et al.Low-Grade Albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals.Circulation,2005,112:969-975.
17 Mann JF,Gerstein HC,Pogue J,et al.Renal insufficiency a predictor of cardiovascular outcomes and the impact of ramipril:the HOPE randomized trial.Ann Intern Med,2001,134(8):629-636.
18 Wathtell K,Palmieri V,Olsen MH,et al.Urine albumin/creatine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertropy:the LIFE study.Losantan intervention for Endpoint Reduction.Am Heart J,2002,143:319.
19 Mykkanen L,Zaccaro DJ,O’Leary DH,et al.Microalbuminuria and carotid artery intima-media thickness in non-diabetic and NIDDM subjects.The Insulin Resistance Atherosclerosis Study.Stroke,1997,28:1710-1716.
20 Furtner M,Kiechl S,Mair A,et al.Urinary albumin excretion is independently associated with carotid and femoral artery atheroclerosis in the general population.Eur Heart J,2005,26:279-287.
21 Yuyun MF,Khaw KT,Luben R.Microalbuminuria,cardiovascular risk factors and cardiovascular morbidity in a British population:the EPIC-Norfolk population-based study.Eur J Cardiovasc Prev Rehabil,2004,11:207-213.
22 ACE Inhibitors in Diabetic Nephropathy Trialist Group,Should all patients with type 1 diabetes mellitus and microalbuminuia receive angiotensin converting enzyme inhibitors? A meta-analysis of individual patient data.Ann Intern Med,2001,134:370-379.
23 Viberti GC,Wheelden NM.For the microalbuminuria reduction with VALsartan(MARVAL)study.Investigators:microalbuminuria reduction with valsartan in patients with the type 2 diabetes mellitus:a blood pressure-independent effect.Circulation,2002,106:672-678.
24 Jacobsen P,Andersen S,Rossing K,et al.Dual blokade of rennin-angiotensin system versus miximal recommenend d上一页 [1] [2] [3] [4] [5] [6] 下一页 上一个医学论文: 甲状腺功能减退性心脏病15例误诊分析 下一个医学论文: 来氟米特及甲氨蝶呤对早期严重类风湿关节炎的治疗作用
|
|
|
|
|
|
|